Exelixis
EXEL
400 hedge funds and large institutions have $4.31B invested in Exelixis in 2022 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 155 increasing their positions, 123 reducing their positions, and 37 closing their positions.
81% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 37
29% more call options, than puts
Call options by funds: $18.2M | Put options by funds: $14.1M
26% more repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 123
7% more funds holding
Funds holding: 373 → 400 (+27)
0.13% less ownership
Funds ownership: 86.29% → 86.15% (-0.13%)
25% less capital invested
Capital invested by funds: $5.73B → $4.31B (-$1.42B)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Top Buyers
Top Sellers
EXEL Hedge Fund Activity: Q3 2022 in Review
400 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q3 2022, worth a combined $4.31B — down 25% from $5.73B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new EXEL positions and 37 closed out — a net gain of 30 holders — while 155 added to existing stakes and 123 trimmed.
The largest buyer was Los Angeles Capital Management, opening a new position worth an estimated $33.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $104M.
- 400 institutional investors held Exelixis (EXEL) as of Q3 2022, up from 373 in Q2 2022.
- Funds reported $4.31B of Exelixis stock for Q3 2022, down 25% quarter-over-quarter.
- 67 funds opened new Exelixis positions in Q3 2022 and 37 closed out, a net change of +30 holders.
- The largest Exelixis buyer in Q3 2022 was Los Angeles Capital Management, an estimated $33.8M added.
- The largest Exelixis seller in Q3 2022 was T. Rowe Price Associates, an estimated $104M sold.
Based on aggregated 13F filings for Q3 2022.